FDA
-
-
-
-
-
-
-
aTyr Pharma schedules FDA meeting for efzofitimod drug program
-
-
-
-
-
-
-
aTyr's efzofitimod misses primary endpoint in sarcoidosis trial
-
-
-
-
-
-
-
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
-
-
-
-
323,583 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

